0      0


ISPT03b - Discover the Impact of GEMTESA® (Vibegron) 75mg Tablets, An Effective OAB Treatment: A Fresh Look at OAB Management in Long-Term Care Settings (Sponsored by Urovant Sciences)


‐ Mar 25, 2022 12:20pm


Credits: None available.

Industry-Supported Presentation Theater

Lunch will be provided. Attendees will be admitted on a first-come basis.

Supported by Urovant Sciences.

This presentation theater discusses the clinical profile and prescribing information for GEMTESA® for the treatment of overactive bladder. The presentation also reviews challenges associated with overactive bladder in long-term care.


Credits

Credits: None available.